Endometriosis is a disease that is often diagnosed late and that may lead to significant reduction in quality of life and serious complications (e.g., infertility). We aimed to assess the prevalence and the annual, nationwide health insurance treatment cost of endometriosis in Hungary using a quantitative, descriptive, cross-sectional method, focusing on the year 2019. We used claims data obtained from the Hungarian National Health Insurance Fund Administration (NHIFA). Patient numbers, total and age-specific prevalence, annual health insurance expenditure, and the distribution of costs across age groups were determined. The NHIFA spent a total of HUF 619.95 million (EUR 1.91 million) on endometriosis treatment. The highest number of patients and prevalence (10,058 women, 197.3 per 100,000) were found in outpatient care. In acute inpatient care, prevalence was substantially lower (23.5 per 100,000). Endometriosis, regardless of its type, affects 30–39-year-olds in the highest number: 4397 women (694.96 per 100,000) in this age group were affected in 2019. The average annual health insurance expenditure per capita was EUR 189.45. In addition to early detection and diagnosis of endometriosis, it is of pivotal importance to provide adequate therapy to reduce costs and reduce the burden on the care system.

The study aimed to investigate the impact of hip replacement surgery on the quality of life and to compare the outcomes by sociodemographic and surgical data in Hungarian public and private hospitals. Patients were selected at the Department of Orthopaedics (Clinical Centre, University of Pécs) and at the Da Vinci Private Clinic in Pécs. Patients completed the SF-36 and Oxford Hip Score (OHS) questionnaires before the surgery, 6 weeks and 3 months later. We also evaluated socio-demographic data, disease and surgical conditions. The research involved 128 patients, 60 patients in public, 68 patients in private hospital. Despite the different sociodemographic characteristics and surgical outcomes of public and private healthcare patients, both groups had significantly improved the quality of life 3 months after hip replacement surgery measured by OHS and SF-36 physical health scores (p < 0.001). In the mental health score, only the patients of the private health sector showed a significant improvement (p < 0.001). The extent of improvement did not differ between the two healthcare sectors according to the OHS questionnaire (p = 0.985). While the SF-36 physical health score showed a higher improvement for public patients (p = 0.027), the mental health score showed a higher improvement for private patients (p = 0.015).

Food supply has an impact on the prevalence of diet-related non-communicable diseases. We aimed to analyze the protein, fat (g/capita/day) and calorie (kcal/capita/day) supply from 2000 to 2019 as derived from the OECD Health Statistics database. A joinpoint regression was used to examine the number and location of breakpoints in the time series. The annual percent change (APC) was calculated using Joinpoint 4.9.0.0. The per capita daily kcal per nutrient was calculated for each country and the resulting percentage distributions were compared to the acceptable macronutrient distribution ranges. Protein, fat and calorie supplies have increased significantly between 2000 and 2019. Each started to show a much steeper, positive change between 2012 and 2014 (APC_fat: 1.0; 95%CI: 0.8–1.1; APC_protein: 0.5; 95%CI: 0.3–0.6; APC_kcal: 0.4; 95%CI: 0.3–0.5). In terms of the composition of the daily calorie intake per capita, the overall share of fat (+4.9%) and protein (+1.0%) increased between 2000 and 2019. We found significant differences among countries and also an increasing and optimal proportion of consumed protein per total calorie in all countries over the last two decades. We concluded that several countries have access to fat availability above the optimal level, which deserves particular attention from health policy makers in the fight against obesity and diet-related diseases.

Objectives: Diabetes in pregnancy represents a significant public health concern with established impacts on both maternal and fetal health outcomes. Our aim was to evaluate the epidemiology of diabetes mellitus in pregnancy (DMP) and specific fetal and neonatal transient metabolic disorders (FNTMDs) in Hungary between 2010 and 2024, as well as to project future trends through to 2035. Methods: We carried out a quantitative, retrospective study using nationwide real-world data from the Hungarian ‘Pulvita’ Health Data Warehouse. ICD-10 codes O24.0–O24.9 (DMP) and P70.0–P70.9 (FNTMDs) were included. Annual patient numbers, the number of hospital days, and the number of DMP patients per 1000 women aged 15–49, as well as the number of FNTMD patients per 1000 live births, were analyzed with joinpoint regression analysis and different forecasting models to project future prevalence up to 2035. Results: Despite a 14.2% decrease in live births, DMP cases increased significantly (54.9% inpatient, 26.6% outpatient), with GDM incidence per thousand reproductive-age women rising by 85.7%. FNTMD cases showed similar trends, with GDM-related infant syndromes more than doubling (154% increase). Projections indicate that DMP prevalence could reach 4.60 per 1000 reproductive-age women by 2035, while FNTMD cases show varying trends between inpatient (increasing) and outpatient (stabilizing) care. Conclusions: These findings demonstrate a continuing upward trend in diabetes-related pregnancy complications, despite shorter hospital stays, suggesting an urgent need for enhanced preventive programs and specialized care service planning.

Background: Endometriosis is one of the most common gynecological diseases that can lead to infertility. The aim of this quantitative, descriptive, and cross-sectional study was to analyze the prevalence and the annual nationwide health insurance treatment cost of endometriosis in Hungary in 2010 and 2019. Methods: The data used in this study were sourced from publicly funded, national, real-world datasets administered by the National Health Insurance Administration (NHIFA). The total number of cases of endometriosis in the Hungarian population was determined by ICD codes and all types of care. The total prevalence, age-specific prevalence, and annual health insurance expenditure by age group were evaluated. Results: The highest numbers of patients and prevalence (2010: 101.9/100,000 women; 2019: 197.3/100,000 women) were found in outpatient care. Endometriosis, regardless of its type, mainly affects patients in the 30–39-year age group (number of patients—2010: 6852; 2019: 11,821). The NHIFA spent a total of EUR 1,639,612 on endometriosis treatment in 2010 and EUR 1,905,476 in 2019. The average annual health insurance expenditure per capita was EUR 574 in 2010 and EUR 426 in 2019. There was a significant correlation between length of stay and mean age of patients in both years (2010 r = 0.856, p < 0.001; 2019 r = 0.877, p < 0.001). Conclusions: The number endometriosis cases is increasing. Early diagnosis and targeted treatment would reduce endometriosis symptoms and therefore improve patients’ quality of life and reduce health insurance costs. This would be helped by the establishment of endometriosis centers.

Háttér és cél – A stroke súlyos egészségügyi probléma, ami jelentős hatással van az egészséggel összefüggő életminőségre. Annak ellenére, hogy egyre népszerűbb az életminőség mérése a betegek körében, nem mérik rendszeresen a klinikai gyakorlatban, ebből kifolyólag kevéssé ismert, hogy a klinikai mérések mennyire tükrözik a stroke utáni életminőséget. Kutatásunk célja az akut ischaemiás stroke-on átesett betegek életminőségének vizsgálata volt. Módszerek – A prospektív vizsgálatba a Pécsi Tudományegyetem Klinikai Központ Neurológiai Klinika akut ischaemiás stroke diagnózissal felvett betegeit kényelmi mintavétellel választottuk ki 2022 júniusa és 2023 májusa között. A betegeket a kapott kezelések alapján intravénás thrombolysis- (IVT-), mechanikus thrombectomia- (MT-) és standard ellátás- (SC-) csoportokba soroltuk. A kutatásban módosított Rankinskálát (Pre-mRS, follow-up mRS), NIH Stroke Scale-t (NIHSS) és European Quality of Life 5 Dimensions Scale-t (EQ-5D-5L) használtunk. Az elemzéshez leíró statisztikát, párosított T-próbát, Wilcoxon-próbát, McNemar-tesztet és Pearson-korrelációt alkalmaztunk (SPSS 25.0; p < 0,05). Eredmények – A kutatásban 198 fő (115 férfi, 83 nő) vett részt (MT: 50 fő, IVT: 69 fő, SC: 79 fő). A Pre-mRS, illetve a follow-up mRS-értékeknél látható, hogy mindhárom csoport esetében a 0–2 közötti, enyhe kategóriába került a legtöbb beteg (PremRS: 176 fő; 88%, follow-up mRS: 158 fő; 80%). A NIHSS-értékek alakulása kapcsán mindhárom csoportban szignifikáns javulást tapasztaltunk (IVT: 4,36 vs. 1,57, p<0,001; MT: 8,98 vs. 4,50, p<0,001; SC: 4,38 vs. 2,84, p < 0,001). Az EQ-5D-5L-érték szintén minden csoport esetében szignifikánsan nőtt (IVT: 0,82 vs. 0,88, p<0,001; MT: 0,63 vs. 0,73, p<0,001, SC: 0,76 vs. 0,80, p=0,014). Az alacsonyabb NIHSS-értékkel felvett betegek jobb életminőségről számoltak be vizsgálatunk végére (r: –0,43451). Következtetés – A 30. napnál az EQ-5D-5L életminőség tekintetében az MT-, IVT- és SC-csoportokban szignifikáns javulást tapasztaltunk, ám a javulás mértéke az MT-csoportban volt a legmagasabb.